With just over a week into his second term, President Donald Trump faces a major policy challenge: tackling Big Pharma and lowering prescription drug prices. A recent Gallup poll shows that while only 34 percent of Americans trust both him and Congress to get the job done, Trump alone performs better: 43 percent believe he will prioritize reducing prescription costs.
That’s a crucial distinction. While Republicans rallied behind him in 2024, and key swing states secured his victory, public confidence in Congress remains abysmally low at just 17 percent. This means that if Trump wants to make an impact on drug pricing, he will have to pressure both Republicans and Democrats in Congress to fall in line.
The Problem: Pharma’s Influence in Washington
Most Americans don’t follow the intricacies of health care policy, but they do recognize when corporate…
